Core Scientific Inc vs Honeywell International Inc — how do they compare? Core Scientific Inc trades at $15.46 (market cap $4.94B), while Honeywell International Inc trades at $207.77 (market cap $65.48B). The key difference: Honeywell International Inc is far larger — about 13.3× Core Scientific Inc's market cap, and Honeywell International Inc pays a 1.36% dividend while Core Scientific Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Core Scientific Inc for 20 Days and Honeywell International Inc for 91 Days on average.
| CORZ | HON | |
|---|---|---|
Market Cap | $4.94B | $65.48B |
Volume | 15,630,800 | 2,047,782 |
Sector | Technology | Industrials |
52-Week High | $29.16 | $248.79 |
52-Week Low | $13.57 | $188.14 |
Typical Hold Time | 20 Days | 91 Days |
Enterprise Value | $7.46B | $90.27B |
Dividend Yield | — | 1.36% |
Signals from Pluang's Aura AI — not financial advice
Core Scientific (CORZ) trades at $15.30, down 4.02% today amid bearish technical signals and negative earnings momentum. The stock faces fundamental challenges with a net income margin of -324.9% and three consecutive quarterly earnings misses. However, analyst sentiment remains overwhelmingly positive with 86% buy ratings and a $32.75 consensus price target, while recent executive appointments and AI infrastructure developments provide potential catalysts.
Despite current financial struggles, CORZ shows potential through its pivot to AI data center services and strong institutional support. Key risks include persistent negative profitability, high capital expenditures, and cryptocurrency market volatility. The significant gap between current price and analyst targets suggests upside potential if the company executes its AI infrastructure strategy successfully.
Honeywell International (HON) trades at $207.73, down 0.18% with a bearish technical signal despite strong fundamentals. The company shows robust profitability with 21.58% net margin and 47.43% ROE, trading at attractive valuations (P/E 7.94, EV/EBITDA 6.72). Recent Q2 2026 earnings beat expectations, and the company secured a $300 million refinery project with Dangote. Analyst consensus remains strongly bullish with 67% buy ratings and $259.25 price target, representing 25% upside potential.
HON presents a compelling value opportunity with strong fundamentals and positive analyst sentiment, though technical indicators suggest near-term caution. The company's post-spin focus on automation and recent contract wins provide growth catalysts, while rising debt levels and cyclical industrial exposure pose moderate risks. Wall Street optimism contrasts with current bearish technical positioning, creating potential for convergence if fundamentals drive price action.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.
Read more on CORZ →Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →